Help us understand the experiences of people affected by pancreatic cancer

Have you provided care for multicultural people living with pancreatic cancer?
We need to hear from you.
Cancer Australia is developing The National Pancreatic Cancer Roadmap, a plan to improve outcomes for people living with pancreatic cancer. The Federation of Ethnic Communities’ Councils of Australia (FECCA) aims to capture the insights of healthcare professionals experienced with people from multicultural backgrounds living with this disease. FECCA will report its findings to Cancer Australia, to ensure the National Pancreatic Cancer Roadmap includes the needs of people from our communities.
Tell us your stories and theirs. Advocate on their behalf.
Complete a survey. Write to us. Talk to us over the phone.
We will keep your personal details secure and safe.

Cancer Australia is a Government Agency set up in 2006 to make things better for all Australians affected by cancer, and their families and carers.
Cancer Australia makes recommendations to the Australian Government about how to improve the lives of people affected by cancer and make sure all people have the same access to services and treatments.
Cancer Australia works with health and medical services, researchers and community groups. The agency also focuses on populations who may have poorer health outcomes, including Aboriginal and Torres Strait Islander peoples, people living in rural and remote Australia and people from different ethnic and multicultural backgrounds.

FECCA is the Federation of Ethnic Communities’ Councils of Australia (FECCA).
It is the national organisation which represents Australians from different ethnic and multicultural communities.
FECCA has member organisations in each State and Territory and in many regions of Australia. The role of FECCA is to advocate on behalf of those communities about issues that affect them. FECCA has recently advised the Australian Government about the special needs of people from different ethnic communities in aged care and COVID-19.